LUMABS BV
PrivateCompany Overview
LUMABS BV is a biotechnology company that develops next-generation bioluminescence-based immunoassay platforms for rapid, sensitive, and quantitative biomolecule detection.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Medical Devices, Biotech Equipment
Business Model
B2B
Customer Profile
Services & Consulting, Data as a Service
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
LUMABS BV Comparables
Compare LUMABS BV with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| BioAuxilium Technologies | 77% | |
| Revvity, Inc. | 70% | |
| Promega Corporation | 70% | |
LUMABS BV Funding Rounds
Historical fundraising activity
LUMABS BV Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| NLC Health Ventures | Seed |
Market signals
Structured signals derived from secondary market and firmographic data.
- Oct 29, 2024
Monthly visitors grew 310% MoM, reaching 1.7K.
LUMABS BV Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about LUMABS BV's valuation, stock price, and market status.